A recent study suggested that IGF2BP2 can combine with PD-L1 to promote the proliferation and inhibit the apoptosis of hypopharyngeal carcinoma cells through the PD-1/PD-L1 axis (38). This evidence concerns the gene PDCD1 and hypopharyngeal carcinoma.